Pure Global
NCT05120999

Comparison of Onset of Neuromuscular Blockade With Electromyographic and Acceleromyographic Monitoring

Comparison of Onset of Neuromuscular Blockade With Electromyographic and Acceleromyographic Monitoring: A Prospective, Randomized Trial
Mayo Clinic·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Neuromuscular Blockade
Drug/Device/Intervention
Train of four measurement
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Mayo Clinic
Location
Jacksonville, United States of America
Timeline & enrollment
Phase
N/A
Start date
Oct 25, 2021
End date
Jan 14, 2022
Enrollment
100 participants
Primary outcome

Time difference

Summary

The purpose of this research is to use 2 devices to compare the difference in the amount of
 time it takes for each device to register complete muscle relaxation after the muscle
 relaxing medication is given. The comparison will be made by using electromyographic (EMG),
 such as TetraGraph, and acceloromyographic (AMG), such as TOFScan, monitors at the time of
 insertion of breathing tube.

ICD-10 classifications
Skeletal muscle relaxants [neuromuscular blocking agents]Poisoning: Skeletal muscle relaxants [neuromuscular blocking agents]Other neuromuscular dysfunction of bladderNeuromuscular dysfunction of bladder, unspecifiedNeuromuscular scoliosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05120999
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05120999 through Pure Global AI's free database. This phase not specified trial is sponsored by Mayo Clinic and is currently Completed. The study focuses on Neuromuscular Blockade. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.